FTSE 100 Drifts Down Slightly After BoE's Expected 25-basis Point Rate Cut

The Bank of England's Monetary Policy Committee voted 5-4 to cut the Bank Rate by 25 basis points to 3.75% (from 4.00%), its lowest level since February 2023, after UK inflation fell to an eight-month low; Governor Andrew Bailey said rates remain on a gradual downward path. UK equities pared earlier gains with the FTSE 100 retreating to 9,771.80 (after a high of 9,805.65), while sector movers included Whitbread (+5.4%), Rentokil (+3.1%) and Metlen Energy & Metals (+2.3%) versus declines in names such as Burberry (~-2%). Investors are now positioned for the ECB policy decision and upcoming US inflation/PCE data, making the BoE move dovish but broadly priced in.

Analysis

Market structure: The BoE’s 25bp cut (to 3.75%) re-rates short-term discounting and favors cyclical UK domestics and exporters via a likely near-term GBP weakness of ~1–2% and lower front-end yields; clear winners in the session were consumer-facing names (Whitbread, Rentokil/RTO) and commodity-linked miners, while UK banks (NWG) face NIM compression and defensives like GSK saw profit-taking as money rotated into cyclicals. Expect 3–6 month relative outperformance of select consumer services and industrials vs. financials by mid-single digits if rates stay on a gradual downtrend.

Risk assessment: Key tail risks include a >150bp inflation resurgence over 6–12 months forcing a policy U-turn (low-probability, high-impact), a >3% GBP shock that dents imported-input companies, or an unexpected ECB/U.S. inflation surprise this week reversing risk appetite. Near-term (days) risk centers on ECB + U.S. CPI/PCE; short-term (weeks) is earnings and retail data; long-term (quarters) is durability of demand and margin structure under lower rates. The 5–4 vote exposes policy fragility — second-order risk is policy credibility hit that could amplify GBP volatility.

Trade implications: Tactical longs: selective cyclicals and exporters (establish 2–3% position in RTO for 3–6 months), tactically short UK banks (NWG 1–2% short) to play NIM squeeze; execute pair trade long RTO / short NWG to isolate macro. Options: buy 3-month NWG 10% OTM put / 5% OTM put debit spread (size 0.5–1% portfolio risk) to cap cost; buy RTO 3–6 month call spread to leverage consumer reopening. Rotate portfolio overweight to consumer discretionary and industrials, underweight banks and utilities until CPI/PCE confirm trend.

Contrarian angles: Consensus discounts limited valuation upside from lower rates — but the market may be underpricing earnings leverage in leisure/services into H2 2025; conversely defensive pharma (GSK) could be oversold if rates keep falling and multiples expand. If GBP stabilizes or ECB stays hawkish, cyclicals can reverse quickly; consider mean-reversion trades: add small long GSK (1%) on >2% weakness with tight 6–8% stop, and look to trim cyclicals if RPI/CPI prints surprise above 3% y/y.

Key Decisions for Investors

• Establish a 2–3% long position in RTO (Rentokil) sized to portfolio risk tolerance, target horizon 3–6 months; take profits at +20% or trim if RTO underperforms cyclicals by >8% in 6 weeks, stop-loss -12%.
• Initiate a 1–2% short position in NWG (NatWest) to express near-term NIM compression; hedge with a 3-month NWG 10% OTM put / 5% OTM put debit spread sized to 0.5–1% portfolio risk; cover/ reassess after ECB and US PCE prints.
• Implement a pair trade: long RTO vs short NWG (ratio 2:1 by notional) for 3–6 months to isolate cyclical vs bank dispersion; rebalance if GBP moves >1.5% intraperiod.
• Buy a 3–6 month RTO call spread (debit) sized 1% to capture upside from consumer reopening; target 3–6 month implied volatility window and exit on +15–25% absolute gain or after ECB/U.S. inflation surprises.
• On any >2% intraday sell-off in GSK, establish a tactical 1% long position with a protective put (6–8% stop); thesis: defensive re-rate if front-end yields keep falling and market seeks yield/ buybacks over next 3–9 months.